Cargando…

Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers

OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 17...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Meiying, Tan, Shifang, Ren, Tian, Zhu, Zitao, Wang, Kaiyu, Zhang, Lingjie, Meng, Lingsong, Yang, Xuhong, Pan, Teng, Yang, Zhexuan, Zhao, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880468/
https://www.ncbi.nlm.nih.gov/pubmed/36713500
http://dx.doi.org/10.3389/fonc.2022.1073983
_version_ 1784878918331793408
author Cheng, Meiying
Tan, Shifang
Ren, Tian
Zhu, Zitao
Wang, Kaiyu
Zhang, Lingjie
Meng, Lingsong
Yang, Xuhong
Pan, Teng
Yang, Zhexuan
Zhao, Xin
author_facet Cheng, Meiying
Tan, Shifang
Ren, Tian
Zhu, Zitao
Wang, Kaiyu
Zhang, Lingjie
Meng, Lingsong
Yang, Xuhong
Pan, Teng
Yang, Zhexuan
Zhao, Xin
author_sort Cheng, Meiying
collection PubMed
description OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 173 tumors (81 SCSTs in 73 patients and 92 EOCs in 75 patients), who were randomly divided into development and testing cohorts at a ratio of 8:2. Radiomics features were extracted from each tumor, 5-fold cross-validation was conducted for the selection of stable features based on development cohort, and we built radiomics model based on these selected features. Univariate and multivariate analyses were used to identify the independent predictors in clinical features and conventional MR parameters for differentiating SCSTs and EOCs. And nomogram was used to visualized the ultimately predictive models. All models were constructed based on the logistic regression (LR) classifier. The performance of each model was evaluated by the receiver operating characteristic (ROC) curve. Calibration and decision curves analysis (DCA) were used to evaluate the performance of models. RESULTS: The final radiomics model was constructed by nine radiomics features, which exhibited superior predictive ability with AUCs of 0.915 (95%CI: 0.869-0.962) and 0.867 (95%CI: 0.732-1.000) in the development and testing cohorts, respectively. The mixed model which combining the radiomics signatures and traditional parameters achieved the best performance, with AUCs of 0.934 (95%CI: 0.892-0.976) and 0.875 (95%CI: 0.743-1.000) in the development and testing cohorts, respectively. CONCLUSION: We believe that the radiomics approach could be a more objective and accurate way to distinguish between SCSTs and EOCs, and the mixed model developed in our study could provide a comprehensive, effective method for clinicians to develop an appropriate management strategy.
format Online
Article
Text
id pubmed-9880468
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-98804682023-01-28 Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers Cheng, Meiying Tan, Shifang Ren, Tian Zhu, Zitao Wang, Kaiyu Zhang, Lingjie Meng, Lingsong Yang, Xuhong Pan, Teng Yang, Zhexuan Zhao, Xin Front Oncol Oncology OBJECTIVE: To evaluate the diagnostic ability of magnetic resonance imaging (MRI) based radiomics and traditional characteristics to differentiate between Ovarian sex cord-stromal tumors (SCSTs) and epithelial ovarian cancers (EOCs). METHODS: We consecutively included a total of 148 patients with 173 tumors (81 SCSTs in 73 patients and 92 EOCs in 75 patients), who were randomly divided into development and testing cohorts at a ratio of 8:2. Radiomics features were extracted from each tumor, 5-fold cross-validation was conducted for the selection of stable features based on development cohort, and we built radiomics model based on these selected features. Univariate and multivariate analyses were used to identify the independent predictors in clinical features and conventional MR parameters for differentiating SCSTs and EOCs. And nomogram was used to visualized the ultimately predictive models. All models were constructed based on the logistic regression (LR) classifier. The performance of each model was evaluated by the receiver operating characteristic (ROC) curve. Calibration and decision curves analysis (DCA) were used to evaluate the performance of models. RESULTS: The final radiomics model was constructed by nine radiomics features, which exhibited superior predictive ability with AUCs of 0.915 (95%CI: 0.869-0.962) and 0.867 (95%CI: 0.732-1.000) in the development and testing cohorts, respectively. The mixed model which combining the radiomics signatures and traditional parameters achieved the best performance, with AUCs of 0.934 (95%CI: 0.892-0.976) and 0.875 (95%CI: 0.743-1.000) in the development and testing cohorts, respectively. CONCLUSION: We believe that the radiomics approach could be a more objective and accurate way to distinguish between SCSTs and EOCs, and the mixed model developed in our study could provide a comprehensive, effective method for clinicians to develop an appropriate management strategy. Frontiers Media S.A. 2023-01-13 /pmc/articles/PMC9880468/ /pubmed/36713500 http://dx.doi.org/10.3389/fonc.2022.1073983 Text en Copyright © 2023 Cheng, Tan, Ren, Zhu, Wang, Zhang, Meng, Yang, Pan, Yang and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Cheng, Meiying
Tan, Shifang
Ren, Tian
Zhu, Zitao
Wang, Kaiyu
Zhang, Lingjie
Meng, Lingsong
Yang, Xuhong
Pan, Teng
Yang, Zhexuan
Zhao, Xin
Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title_full Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title_fullStr Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title_full_unstemmed Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title_short Magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
title_sort magnetic resonance imaging radiomics to differentiate ovarian sex cord-stromal tumors and primary epithelial ovarian cancers
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880468/
https://www.ncbi.nlm.nih.gov/pubmed/36713500
http://dx.doi.org/10.3389/fonc.2022.1073983
work_keys_str_mv AT chengmeiying magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT tanshifang magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT rentian magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT zhuzitao magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT wangkaiyu magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT zhanglingjie magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT menglingsong magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT yangxuhong magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT panteng magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT yangzhexuan magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers
AT zhaoxin magneticresonanceimagingradiomicstodifferentiateovariansexcordstromaltumorsandprimaryepithelialovariancancers